13.36
-0.55
(-3.95%)
At close: January 31 at 4:00:02 PM EST
13.99
+0.63
+(4.72%)
After hours: 7:12:33 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 195,734,675 | 92 |
Sales | 83,479,144 | 332 |
Net Shares Purchased (Sold) | 112,255,533 | 424 |
Total Insider Shares Held | 3.64M | -- |
% Net Shares Purchased (Sold) | -103.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
COEN STEVEN P. Officer | Sale at price 11.72 per share. | Direct | 3,797 | Jan 6, 2025 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 11.72 per share. | Direct | 7,558 | Jan 6, 2025 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Jan 3, 2025 |
COEN STEVEN P. Officer | -- | Direct | -- | Jan 3, 2025 |
COEN STEVEN P. Officer | Sale at price 9.64 per share. | Direct | 3,183 | Dec 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 9.64 per share. | Direct | 7,146 | Dec 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Dec 3, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Dec 3, 2024 |
COEN STEVEN P. Officer | Sale at price 7.58 per share. | Direct | 2,523 | Nov 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 7.58 per share. | Direct | 10,015 | Nov 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Nov 1, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Nov 1, 2024 |
COEN STEVEN P. Officer | Sale at price 8.35 per share. | Direct | 2,555 | Oct 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 8.35 per share. | Direct | 10,163 | Oct 4, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Oct 3, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Oct 3, 2024 |
COEN STEVEN P. Officer | Sale at price 6.17 per share. | Direct | 1,950 | Sep 12, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 6.17 per share. | Direct | 7,085 | Sep 12, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Sep 11, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Sep 11, 2024 |
COEN STEVEN P. Officer | Sale at price 0.29 per share. | Direct | 5,018 | Aug 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 0.29 per share. | Direct | 18,244 | Aug 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Aug 1, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Aug 1, 2024 |
COEN STEVEN P. Officer | Sale at price 0.33 per share. | Direct | 4,408 | Jul 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 0.33 per share. | Direct | 16,027 | Jul 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Jul 1, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | Jul 1, 2024 |
SLOAN HARRY EVANS Director | -- | Direct | -- | Jun 12, 2024 |
DEKKERS MARIJN E Director | -- | Direct | -- | Jun 12, 2024 |
HENRY CHRISTIAN O Director | -- | Direct | -- | Jun 12, 2024 |
BELLDEGRUN ARIE S Director | -- | Direct | -- | Jun 12, 2024 |
KEWALRAMANI RESHMA Director | -- | Direct | -- | Jun 12, 2024 |
HANNAN KATHY HOPINKAH Director | -- | Direct | -- | Jun 12, 2024 |
SANKAR SHYAM Director | -- | Direct | -- | Jun 12, 2024 |
COEN STEVEN P. Officer | Sale at price 0.55 per share. | Direct | 7,379 | Jun 3, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 0.55 per share. | Direct | 26,827 | Jun 3, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | May 31, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | May 31, 2024 |
DEKKERS MARIJN E Director | Sale at price 0.83 per share. | Indirect | 220,030 | May 16, 2024 |
SANKAR SHYAM Director | Purchase at price 0.82 per share. | Direct | 514,750 | May 15, 2024 |
SLOAN HARRY EVANS Director | Purchase at price 0.91 per share. | Direct | 271,815 | May 14, 2024 |
DEKKERS MARIJN E Director | Sale at price 0.93 per share. | Direct | 1,606,162 | May 14, 2024 |
COEN STEVEN P. Officer | Sale at price 0.84 per share. | Direct | 111,479 | May 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 0.84 per share. | Direct | 40,396 | May 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | May 1, 2024 |
COEN STEVEN P. Officer | -- | Direct | -- | May 1, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 1.05 per share. | Direct | 53,727 | Apr 2, 2024 |
DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Apr 1, 2024 |
DMYTRUK MARK E Chief Financial Officer | Sale at price 1.26 per share. | Direct | 48,765 | Mar 4, 2024 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
10.32
-1.81%
RXRX Recursion Pharmaceuticals, Inc.
7.24
-5.85%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
VERV Verve Therapeutics, Inc.
7.61
+2.70%
EDIT Editas Medicine, Inc.
1.3100
-4.38%
IBRX ImmunityBio, Inc.
3.4500
-0.58%
ABCL AbCellera Biologics Inc.
3.1700
-1.86%
BLUE bluebird bio, Inc.
7.75
-2.02%
ETNB 89bio, Inc.
9.60
-0.41%